Eversense 365 CGM
Introducing Eversense 365. The only CGM that lasts a year.
Wave a long goodbye to traditional, short-term CGMs. Eversense® 365 gives you one year of real-time continuous glucose readings with minimal device frustrations.
- Longest lasting CGM. Eversense is the only CGM that lasts for a year.1-3
- No more wasted CGMs. The tiny sensors are designed to rest comfortably under your skin. Plus, our removable smart transmitter can be taken off* and put back on without wasting a CGM.
- Alerts you can trust. Eversense CGMs have exceptional accuracy, with almost no false alerts from compression lows while you’re sleeping.4
- Maximum comfort. Our gentle, silicone-based adhesives are changed daily and cause almost no skin reactions.5
Ready to get started with Eversense?
Click here to email our Diabetes Care team today to learn more. You’ll be paired with an Eversense expert who will guide you every step of the way. You can also enroll online here.
Only one sensor placement and warm-up period every year and just one fingerstick calibration required weekly after day 13; no risk of losing your sensor and essentially compression lows5
Exceptional accuracy over one year and is the most accurate CGM in the low range3 you can get; 99% of high and 94% of low glucose events detected correctly3
Water-resistant transmitter* provides real-time glucose readings every 5 minutes and distinct on-body vibe alerts even when you’re away from your phone or smart device
Only app with predictive high and low alerts and allows you to share data without lengthy downloads; compatible with Android and iOS systems
Frequently Asked Questions
Eversense gives you real-time glucose readings through a small sensor that’s placed just under the skin of your upper arm by a healthcare provider. The smart transmitter sits above the sensor, sending glucose data to your app.
The main difference between Eversense 365 and Eversense E3 is that Eversense 365 lasts for one year.
The tiny sensor is placed just under the skin of your upper arm by a trained healthcare provider. There’s a small incision which is then closed with Steri-Strips (which you can remove within a few days) – no stitches involved. Then you’re good to go for one year!
The mild, silicone-based adhesives are changed daily and are gentle on the skin with almost no skin reactions (1%).5
Download this discussion guide and bring it to your next appointment and talk to your doctor about how Eversense may be a better fit for your diabetes management plan. We will work with you and your healthcare provider to manage your insurance claim.
We encourage you to also reach out to our Diabetes Care team to learn more about qualifying for Eversense 365. You can apply online, email us at dca@myehcs.com, or call 800-951-1725 to learn more.
* There is no glucose data generated when the transmitter is removed
1. Abbott. (2024) Freestyle Libre 3 User Guide ART49385-001 Rev. A 04/24
2. Dexcom (2024) G7 User Guide AW00078-10 Rev 003 MT-00078-10
3. Senseonics. (2024) Eversense 365 Continuous Glucose Monitoring System User Guide. LBL-7702-01-001
4. Christiansen MP et al. A Prospective Multicenter Evaluation of the Accuracy of a Novel Implanted Continuous Glucose Sensor: PRECISE II. DIABETES TECHNOLOGY & THERAPEUTICS 2018; 20(3):197-206
5. Deiss, D. et al. (2020). Real-world safety of an implantable continuous glucose sensor over multiple cycles of use: A post-market registry study. Diabetes Technology and Therapeutics, 22(1), 48–52. https://doi.org/10.1089/dia.2019.0159
6. Data on File. Senseonics. Policy Reporter (8/23/2024)
7. Offer does not apply to the insertion and removal procedures. The Eversense PASS Program has limitations on eligibility. See website (bit.ly/EversensePass) for more details. Senseonics reserves the right to change or terminate this program at any time without notice. The program benefit is capped per transaction. There may be instances in which patient out-of-pocket costs exceed what is detailed in the offer. Eversense E3 is not eligible for the PASS Program.
8. Not a guarantee of coverage and payment. A doctor’s prescription is required for Medicare coverage and patients must meet Medicare eligibility coverage criteria. Coverage and payment may be subject to coinsurance, deductible and patient eligibility requirements. Visit http://www.medicare.gov to learn more about Medicare plans and coverage. For additional details, For additional details, visit Eversense Cost & Insurance.
The Eversense® 365 Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels for up to one year in people (18 years and older) with diabetes. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are required for calibration one time a week after day 13, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense 365 CGM System is a prescription device; patients should talk to their health care provider to learn more.
For important safety information, see bit.ly/eversensesafety
Eversense, Eversense E3 Continuous Glucose Monitoring, Eversense 365 Continuous Glucose Monitoring, and the Eversense logo are trademarks of Senseonics, Incorporated. All other trademarks are properties of their respective owners and are used solely for informative purposes. No relationship or endorsement should be inferred or implied.
Apple Watch® is a product of Apple, Inc., and may be separately purchased from an authorized Apple retailer. Apple Watch is not included with the Eversense CGM System. Android is a trademark of Google LLC.